Simplex Trading’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-117
Closed 8778
2024
Q2
$0 Buy
117
+69
+144% +$482 ﹤0.01% 9046
2024
Q1
$0 Buy
48
+46
+2,300% +$384 ﹤0.01% 9112
2023
Q4
$0 Sell
2
-38
-95% -$239 ﹤0.01% 9056
2023
Q3
$0 Sell
40
-8
-17% -$70 ﹤0.01% 8962
2023
Q2
$0 Sell
48
-20
-29% -$135 ﹤0.01% 9220
2023
Q1
$0 Hold
68
﹤0.01% 9311
2022
Q4
$0 Buy
68
+20
+42% +$141 ﹤0.01% 9494
2022
Q3
$0 Buy
+48
New +$463 ﹤0.01% 10159
2022
Q2
Sell
-599
Closed -$5.86K 10228
2022
Q1
$7K Sell
599
-762
-56% -$10.3K ﹤0.01% 9160
2021
Q4
$22K Buy
1,361
+43
+3% +$976 ﹤0.01% 8250
2021
Q3
$44K Hold
1,318
﹤0.01% 7652
2021
Q2
$45K Sell
1,318
-525
-28% -$20.6K ﹤0.01% 7768
2021
Q1
$92K Buy
+1,843
New +$114K ﹤0.01% 5863

Other funds holding EVGN

Simplex Trading's EVGN Position: Q3 2024 in Review

Simplex Trading sold out of Evogene (EVGN) in Q3 2024, closing a stake of 117 shares.

Simplex Trading first reported a position in EVGN in Q1 2021 and held it in 13 quarters. The position peaked at $92K in Q1 2021. 14 funds tracked by Wall St. Rank hold EVGN as of Q3 2024.

  • Simplex Trading reported no remaining Evogene position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 117 Evogene shares in Q3 2024.
  • Simplex Trading first reported a position in Evogene in Q1 2021 and held it in 13 quarters.
  • Simplex Trading's Evogene position peaked at $92K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Evogene as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.